Issue navigation
Volume 6, Issue 1, March 2024
Critical Reviews and Perspectives
How snoRNAs can contribute to cancer at multiple levels
NAR Cancer, Volume 6, Issue 1, March 2024, zcae005, https://doi.org/10.1093/narcan/zcae005
METTL3 as a master regulator of translation in cancer: mechanisms and implications
NAR Cancer, Volume 6, Issue 1, March 2024, zcae009, https://doi.org/10.1093/narcan/zcae009
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
NAR Cancer, Volume 6, Issue 1, March 2024, zcae012, https://doi.org/10.1093/narcan/zcae012
Cancer Computational Biology
A large-scale study of peptide features defining immunogenicity of cancer neo-epitopes
NAR Cancer, Volume 6, Issue 1, March 2024, zcae002, https://doi.org/10.1093/narcan/zcae002
Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome
NAR Cancer, Volume 6, Issue 1, March 2024, zcae010, https://doi.org/10.1093/narcan/zcae010
Cancer Data Resource
CanVaxKB: a web-based cancer vaccine knowledgebase
NAR Cancer, Volume 6, Issue 1, March 2024, zcad060, https://doi.org/10.1093/narcan/zcad060
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN
NAR Cancer, Volume 6, Issue 1, March 2024, zcad062, https://doi.org/10.1093/narcan/zcad062
TSCRE: a comprehensive database for tumor-specific cis-regulatory elements
NAR Cancer, Volume 6, Issue 1, March 2024, zcad063, https://doi.org/10.1093/narcan/zcad063
dbCRAF: a curated knowledgebase for regulation of radiation response in human cancer
NAR Cancer, Volume 6, Issue 1, March 2024, zcae008, https://doi.org/10.1093/narcan/zcae008
Cancer Gene Regulation, Chromatin, and Epigenetics
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
NAR Cancer, Volume 6, Issue 1, March 2024, zcae004, https://doi.org/10.1093/narcan/zcae004
Cancer Genomics
Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance
NAR Cancer, Volume 6, Issue 1, March 2024, zcad061, https://doi.org/10.1093/narcan/zcad061
DNA Damage Sensing and Repair
The ORFIUS complex regulates ORC2 localization at replication origins
NAR Cancer, Volume 6, Issue 1, March 2024, zcae003, https://doi.org/10.1093/narcan/zcae003
Human NTHL1 expression and subcellular distribution determines cisplatin sensitivity in human lung epithelial and non-small cell lung cancer cells
NAR Cancer, Volume 6, Issue 1, March 2024, zcae006, https://doi.org/10.1093/narcan/zcae006
SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients
NAR Cancer, Volume 6, Issue 1, March 2024, zcae007, https://doi.org/10.1093/narcan/zcae007
XPA tumor variant leads to defects in NER that sensitize cells to cisplatin
NAR Cancer, Volume 6, Issue 1, March 2024, zcae013, https://doi.org/10.1093/narcan/zcae013
Nucleic Acid-Based Cancer Therapeutics
Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint Inhibitors
NAR Cancer, Volume 6, Issue 1, March 2024, zcad059, https://doi.org/10.1093/narcan/zcad059
The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
NAR Cancer, Volume 6, Issue 1, March 2024, zcae011, https://doi.org/10.1093/narcan/zcae011
Correction
Correction to ‘Translation reprogramming by eIF3 linked to glioblastoma resistance’
NAR Cancer, Volume 6, Issue 1, March 2024, zcae001, https://doi.org/10.1093/narcan/zcae001
